Leading With Intention: Cultivating Joy to Build Resilient Oncology Pharmacy Teams

Author(s)Brette Conliffe, PharmD, BCOP, DPLA

How oncology pharmacy leaders fight burnout with stay surveys, smarter schedules, and recognition—building resilient teams through loss and turnover.

In the spirit of transparency and honesty, I must admit that when I originally committed to writing this article, I felt like our oncology pharmacy team was in a great place. We had worked hard to implement strategies to cultivate joy in the workplace, a topic I felt strongly about and had presented on several times, and we had not experienced any voluntary pharmacist turnover since embarking on this journey.

Related to this article

Pink ribbon for breast cancer awareness -- Image credit: Pixel-Shot | stock.adobe.com

October 13th, 2026

Breast Cancer Is Becoming an At-Home, Long-Haul Disease: Pharmacists as Primary Points of Contact

At-home chemotherapy for HR+ breast cancer works best when pharmacists guide oral regimens, boosting adherence, safety, and affordable access.

Pharmacy researcher developing oncology treatment -- Image credit: scaliger | stock.adobe.com

October 12th, 2026

When Oncology Gets a Blockbuster

Sometimes, a breakthrough matters not only because of what it does for patients today, but because of what it makes possible for tomorrow.

Sometimes you need to combine medicine for maximum effect. Cropped shot of an unrecognizable young female pharmacist working in a pharmacy - Image credit: Arnéll Koegelenberg/peopleimages.com | stock.adobe.com

October 13th, 2026

Ensuring Medication Safety in Special Populations

Managing medication safety in specialized populations requires a shift from standardized dosing to precise, patient-specific customization.

Capsule Unveiling: Drugs Interacting with DNA Helix in a 3D Render on Pharmacogenomics and Pharmacogenetics - Image credit: Vlad | stock.adobe.com

October 12th, 2026

Precision Medicine in Action: The Role of Pharmacogenomics in Guiding Prescribing

Pharmacogenomic-guided prescribing uses genetic data to protect patients from dangerous toxicities and get them the right drug at the right dose from the start.

October 10th, 2026

Patients Report Early, Sustained Functional Gains With First-Line Zongertinib in HER2-Mutant NSCLC

Patients reported that zongertinib resulted in improvements in physical functioning within 1 week of initiating therapy.

raw vegetables with blood glucose meter, syringe, lancet and stethoscope on desk, diabetes healthy diet concept - Image credit: neirfy | stock.adobe.com

October 9th, 2026

The Value of Self-Monitoring Blood Glucose Tools in Preventing and Reducing Prediabetes and Diabetes-Related Complications

As accessible health care providers, pharmacists can raise awareness about the proper use of OTC blood glucose meters and continuous glucose monitoring devices.

3d illustration of human internal organ gallbladder anatomy - Image credit: microscience | stock.adobe.com

October 8th, 2026

Rising Gallbladder Complications With GLP-1 Receptor Agonists Call for Closer Pharmacist Monitoring

Growing evidence points to gallstones and cholecystitis as an underrecognized risk of GLP-1 RA therapy—pharmacists are well positioned to catch it early.

October 7th, 2026

Could CAR T Cells Be Reprogrammed After Infusion to Target Cancer Again?

In an interview with Pharmacy Times, City of Hope researchers discuss a preclinical platform designed to redirect CAR T cells after infusion and how pharmacists could help bring this adaptable approach into clinical practice.